Home
Live
News
Create
Screeners
Insights
Brooks Laboratories
126.
34
-1.77
(-1.38%)
Market Cap
₹377.40 Cr
PE Ratio
184.78
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-1.38%
1M
-19.76%
6M
-10.01%
1Y
-13.88%
5Y
+114.21%
View Company Insights
Latest news about Brooks Laboratories
Brooks Steriscience Approves Multi-Entity Merger Scheme to Consolidate Sterile Injectable Operations
Sep 26, 2025
Brooks Steriscience Limited, a subsidiary of Brooks Laboratories, has approved a significant corporate restructuring plan involving a composite scheme of arrangement and amalgamation of five pharmaceutical entities. The merger aims to consolidate sterile injectable manufacturing operations under OneSource Specialty Pharma Limited. The scheme involves Steriscience Specialties Private Limited, Brooks Steriscience Limited, Steriscience Pte Limited, Strides Pharma Services Private Limited, and OneSource Specialty Pharma Limited. Share exchange ratios have been set, with post-merger promoter shareholding in OneSource expected to increase to 36.17%. The consolidation is designed to strengthen CDMO capabilities, create operational synergies, and enhance shareholder value. The scheme requires approvals from various regulatory authorities.
Brooks Laboratories Reports Robust Q1 FY26 Results with 265.06 Lakh Net Profit
Aug 13, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation